Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.54
-0.80 (-3.16%)
At close: Apr 1, 2025, 4:00 PM
24.61
+0.07 (0.29%)
After-hours: Apr 1, 2025, 7:59 PM EDT
Pfizer Revenue
In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth. Pfizer had revenue of $17.76B in the quarter ending December 31, 2024, with 21.92% growth.
Revenue (ttm)
$63.63B
Revenue Growth
+6.84%
P/S Ratio
2.18
Revenue / Employee
$785,519
Employees
81,000
Market Cap
139.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PFE News
- 12 hours ago - Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks - CNBC
- 23 hours ago - European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease - Reuters
- 23 hours ago - European Commission Approves Pfizer's RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease - Business Wire
- 1 day ago - Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
- 1 day ago - Vaccine stocks fall after key FDA official resigns in protest of RFK Jr. - CNBC
- 1 day ago - Biotech stocks tumble on reports FDA's top vaccine regulator to leave - Reuters
- 4 days ago - 6 Ultra SWANs Potentially Set To Soar In 2025 - Seeking Alpha
- 5 days ago - Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here's What We Know. - Forbes